<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04309591</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01740; ch19Santer</org_study_id>
    <nct_id>NCT04309591</nct_id>
  </id_info>
  <brief_title>Cytosorb Therapy in Cardiac Surgery</brief_title>
  <official_title>Cytosorb Therapy in Cardiac Surgery - a Retrospective Study of Hemoadsorption in Patients With Endocarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiopulmonary surgery is associated with inflammatory responses that can lead to systemic
      inflammatory responses (SIRS), organ dysfunction (MOD) and death especially in patients with
      endocarditis. Cytokine removal might therefore improve outcomes of patients undergoing
      cardiac surgery. CytoSorb is a device designed to remove cytokine (IL-6, IL-10, TNFalpha)
      from the blood to reduce immune reactions. This trial investigates the use of CytoSorb during
      cardiac surgery in patients with endocarditis at the University Hospital Basel.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 18, 2019</start_date>
  <completion_date type="Actual">December 4, 2019</completion_date>
  <primary_completion_date type="Actual">December 4, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-Hospital mortality</measure>
    <time_frame>during hospital stay for cardiac surgery from admission until discharge (approximately 15 days)</time_frame>
    <description>In-Hospital mortality (number of deaths) of patients with endocarditis undergoing cardiac surgery and intra-operative CytoSorb haemoadsorption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time in intensive care unit (days)</measure>
    <time_frame>during hospital stay for cardiac surgery from admission until discharge (approximately 15 days)</time_frame>
    <description>time in intensive care unit (days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-Hospital time (days)</measure>
    <time_frame>hospital stay for cardiac surgery from admission until discharge (approximately 15 days)</time_frame>
    <description>In-Hospital time (days)</description>
  </secondary_outcome>
  <enrollment type="Actual">249</enrollment>
  <condition>Cardiopulmonary Surgery</condition>
  <condition>Endocarditis</condition>
  <condition>Peri-operative Cytokines Levels</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CytoSorb haemoadsorption (HA) device</intervention_name>
    <description>CytoSorb® cartridges contain biocompatible sorbent polystyrene divinylbenzene beads coated with polyvinylpyrrolidone, capable of removing inflammatory molecules (eg Interleukin). The cartridge is inserted in a cardio-pulmonary bypass circuit to remove inflammatory molecules during cardiac surgery .</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with endocarditis undergoing cardiac surgery with cardio-pulmonary bypass circuit
        at the University Hospital Basel
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with endocarditis undergoing cardiac surgery with cardio-pulmonary bypass
             circuit

        Exclusion Criteria:

          -  denial of consent for data use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Santer, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsspital Basel, Herzchirurgie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Herzchirurgie, Universitätsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>March 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2020</study_first_posted>
  <last_update_submitted>March 12, 2020</last_update_submitted>
  <last_update_submitted_qc>March 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cytokine clearance</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>CytoSorb</keyword>
  <keyword>cytokine removal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

